TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30178193

Group type: EXPERIMENTAL
Intervention: Elotuzumab plus lenalidomide plus dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lenalidomide plus dexamethasone
Number of subjects: 0
Study: 26903176

Group type: EXPERIMENTAL
Intervention: NEXit core program with 157 text messages for 12 weeks
Number of subjects: 1590

Group type: COMPARATOR
Intervention: Control group receiving 1 text every 2 weeks
Number of subjects: 1590
Study: 23848167

Group type: EXPERIMENTAL
Intervention: Exercise Group (EG) - acute tri-set resistance training protocol with two combinations of three exercises at 75% of 1RM for six to eight repetitions
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Exercise Group (EG)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Exercise Group (EG) compared to Control Group (CG)
Number of subjects: 18
Study: 22419420

Group type: EXPERIMENTAL
Intervention: Tai Chi training (18 weeks, 45 minutes twice a week)
Number of subjects: 40
Study: 20138583

Group type: EXPERIMENTAL
Intervention: Internet behavioral weight-loss program
Number of subjects: 66
Study: 18608836

Group type: EXPERIMENTAL
Intervention: Morning group (07:00-09:00 h)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Evening group (17:00-19:00 h)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 27
Study: 16210311

Group type: EXPERIMENTAL
Intervention: ProSeal laryngeal mask airway (PLMA)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Classic laryngeal mask airway (cLMA)
Number of subjects: 240
Study: 12401823

Group type: EXPERIMENTAL
Intervention: Patient self management
Number of subjects: 78

Group type: COMPARATOR
Intervention: Routine primary care management
Number of subjects: 78
Study: 10089949

Group type: EXPERIMENTAL
Intervention: Granisetron 40 micrograms/kg by intravenous infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment (group NG)
Number of subjects: 0
Study: 8521310

Group type: EXPERIMENTAL
Intervention: propofol 2.5 mg.kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: propofol 3 mg.kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: propofol 3.5 mg.kg‐1
Number of subjects: 60
Study: 2281103

Group type: EXPERIMENTAL
Intervention: Platelet scintigraphy (PS)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Impedance plethysmography (IPG)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Color flow duplex ultrasound (U)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Venography (V)
Number of subjects: 104
Study: 7446914

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Spinal analgesia
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Psoas compartment block
Number of subjects: 60
Study: 30985703

Group type: EXPERIMENTAL
Intervention: Jaungo (JUG) ointment applied on irradiated skin for 6 weeks, twice a day
Number of subjects: 80

Group type: COMPARATOR
Intervention: General supportive care (GSC)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Jaungo (JUG) ointment
Number of subjects: 80
Study: 27311449

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided interscalene brachus plexus block (ISB) combined with arthroscopy-guided suprascapular nerve block (SSNB)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Ultrasound-guided interscalene brachus plexus block (ISB) alone
Number of subjects: 48
Study: 25872590

Group type: EXPERIMENTAL
Intervention: Nd:YAG 1064 nM laser application (4 sessions)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 64
Study: 23692617

Group type: EXPERIMENTAL
Intervention: Fast-velocity concentric isokinetic resistance training (FV)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 18
Study: 21869688

Group type: EXPERIMENTAL
Intervention: risperidone 2 mg/d
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: sodium valproate 600 mg/d
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: buspirone 30 mg/d
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: trazodone 100 mg/d
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: thyroid hormone 80 mg/d
Number of subjects: 225
Study: 19362361

Group type: EXPERIMENTAL
Intervention: Home delivery of artemether-lumefantrine (n=217)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Home delivery of artemether-lumefantrine (n=189)
Number of subjects: 437

Group type: COMPARATOR
Intervention: Standard care (n=208)
Number of subjects: 437

Group type: COMPARATOR
Intervention: Standard care (n=176)
Number of subjects: 437
Study: 17585029

Group type: EXPERIMENTAL
Intervention: Soy protein isolate (SPI+) (107 mg/d isoflavones)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Alcohol-washed soy protein isolate (SPI-) (<6 mg/d isoflavones)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Milk protein isolate (0 mg/d isoflavones)
Number of subjects: 58
Study: 14718883

Group type: EXPERIMENTAL
Intervention: Anterior open bite extraction treatment
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group with normal occlusion
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 31
Study: 11468762

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10736082

Group type: COMPARATOR
Intervention: Tropisetron alone
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Tropisetron plus dexamethasone
Number of subjects: 125
Study: 8922769

Group type: EXPERIMENTAL
Intervention: Midazolam 0.05 mg.kg‐1
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Midazolam 0.075 mg.kg‐1
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Midazolam 0.10 mg.kg‐1
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Midazolam 0.15 mg.kg‐1
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Midazolam 0.20 mg.kg‐1
Number of subjects: 200
Study: 1359260

Group type: EXPERIMENTAL
Intervention: Excimer laser
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: PTA
Number of subjects: 116

Group type: COMPARATOR
Intervention: All treatments (laser and PTA)
Number of subjects: 116
Study: 3892345

Group type: EXPERIMENTAL
Intervention: Cyclosporine and prednisone
Number of subjects: 63

Group type: COMPARATOR
Intervention: Azathioprine and prednisone
Number of subjects: 63
Study: 31547966

Group type: EXPERIMENTAL
Intervention: TightRope fixation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Screw fixation
Number of subjects: 12
Study: 29363356

Group type: EXPERIMENTAL
Intervention: Lorazepam (n = 51)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (n = 52)
Number of subjects: 103
Study: 26868497

Group type: EXPERIMENTAL
Intervention: LDCT1 (annual screening)
Number of subjects: 2303

Group type: COMPARATOR
Intervention: LDCT2 (biennial screening)
Number of subjects: 2303
Study: 24310562

Group type: EXPERIMENTAL
Intervention: Acipimox (750 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 22499825

Group type: EXPERIMENTAL
Intervention: Acupuncture (needles inserted at points HT7, PC6, CV17, GV20 and Yintang)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (needles inserted in areas near but not corresponding to acupuncture points)
Number of subjects: 43
Study: 22131689

Group type: EXPERIMENTAL
Intervention: Arkapushpa Taila Uttarbasti and Krishna Tila Kwatha administered simultaneously
Number of subjects: 31

Group type: COMPARATOR
Intervention: Krishna Tila Kwatha administered orally
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo wheat powder administered orally
Number of subjects: 31
Study: 17114187

Group type: EXPERIMENTAL
Intervention: Enhanced nasal airflow (high flow unhumidified air with 20 p.p.m. nitric oxide gas)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Bilateral head fanning
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combined effect of airflow and fanning
Number of subjects: 12

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 12
Study: 16046988

Group type: EXPERIMENTAL
Intervention: Allopurinol (administered 4 hours and 1 hour before ERCP)
Number of subjects: 701

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 701
Study: 12172337

Group type: EXPERIMENTAL
Intervention: High-dose fluoxetine (40-60 mg/day)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Fluoxetine plus desipramine (25-50 mg/day)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Fluoxetine plus lithium (300-600 mg/day)
Number of subjects: 101
Study: 10225495

Group type: EXPERIMENTAL
Intervention: Project Northland intervention
Number of subjects: 2351

Group type: COMPARATOR
Intervention: Reference condition
Number of subjects: 2351
Study: 7787916

Group type: EXPERIMENTAL
Intervention: Patients who controlled their bed position (experimental group)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Patients who remained flat in bed (control group)
Number of subjects: 54
Study: 2273939

Group type: EXPERIMENTAL
Intervention: Physical exercise (bicycling on a bicycle ergometer at 50% of MWC for 10 min, followed by 10 min at 80% of MWC)
Number of subjects: 7
Study: 30219843

Group type: EXPERIMENTAL
Intervention: ART initiation
Number of subjects: 860
Study: 25854499

Group type: EXPERIMENTAL
Intervention: Early full weight-bearing (11-day protocol)
Number of subjects: 120

Group type: COMPARATOR
Intervention: 20-kg partial weight-bearing for 6 weeks
Number of subjects: 120
Study: 25495361

Group type: EXPERIMENTAL
Intervention: Project UPLIFT (mindfulness-based cognitive therapy)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 128
Study: 22858191

Group type: EXPERIMENTAL
Intervention: AGE (300 mg/tablet) plus CoQ10 (30 mg/tablet)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 20561879

Group type: EXPERIMENTAL
Intervention: Bathing during weaning trials
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nocturnal bathing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bathing within 1 hour before a trial
Number of subjects: 30
Study: 19125989

Group type: EXPERIMENTAL
Intervention: Bone turnover markers (BTM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bone mineral density (BMD)
Number of subjects: 0
Study: 17329409

Group type: EXPERIMENTAL
Intervention: Metoprolol CR
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study: 14732755

Group type: EXPERIMENTAL
Intervention: OPCABG
Number of subjects: 60

Group type: COMPARATOR
Intervention: ONCABG
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 11180315

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9432335

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg bid) + Amoxicillin (1 gm bid) for 2 weeks
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg bid) + Amoxicillin (1 gm bid) + Metronidazole (500 mg bid) for 1 week
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg bid) + Amoxicillin (1 gm bid) + Clarithromycin (500 mg bid) for 1 week
Number of subjects: 175

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 175
Study: 7945542

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 300 mg daily with ranitidine 150 mg daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) 300 mg daily without ranitidine (Placebo)
Number of subjects: 32
Study: 3283595

Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 31197264

Group type: EXPERIMENTAL
Intervention: Amlodipine + Amiloride/Hydrochlorothiazide
Number of subjects: 9885

Group type: EXPERIMENTAL
Intervention: Amlodipine + Telmisartan
Number of subjects: 9885

Group type: EXPERIMENTAL
Intervention: Statin group
Number of subjects: 9885

Group type: COMPARATOR
Intervention: Routine intervention group
Number of subjects: 9885
Study: 28347877

Group type: EXPERIMENTAL
Intervention: Clonazepam 0.25mg (GABAA agonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo pill
Number of subjects: 0

Group type: COMPARATOR
Intervention: No reminder
Number of subjects: 0
Study: 25192849

Group type: EXPERIMENTAL
Intervention: Microsurgical bilateral decompression via unilateral approach
Number of subjects: 73

Group type: COMPARATOR
Intervention: Single-level LSS surgery
Number of subjects: 73
Study: 23312808

Group type: EXPERIMENTAL
Intervention: Prednisolone and chlorambucil (6 months)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Ciclosporin (12 months)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Supportive treatment only
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Prednisolone and chlorambucil
Number of subjects: 108
Study: 21476152

Group type: EXPERIMENTAL
Intervention: Once-daily tenofovir DF plus emtricitabine (Truvada, TVD) with efavirenz (EFZ)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Zidovudine plus lamivudine (Combivir, CBV) with efavirenz (EFZ)
Number of subjects: 234
Study: 18708148

Group type: EXPERIMENTAL
Intervention: Methamphetamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cocaine
Number of subjects: 0
Study: 16517193

Group type: EXPERIMENTAL
Intervention: Nortriptyline 75 mg/day
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Bupropion 300 mg/day
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Nortriptyline vs Bupropion
Number of subjects: 156
Study: 12652489

Group type: EXPERIMENTAL
Intervention: Direct stenting
Number of subjects: 151

Group type: COMPARATOR
Intervention: Conventional stenting
Number of subjects: 151
Study: 11086783

Group type: EXPERIMENTAL
Intervention: Blind manual method for positioning double-lumen tube (DLT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Conventional method using fiberoptic bronchoscope (FOB)
Number of subjects: 58
Study: 8826548

Group type: EXPERIMENTAL
Intervention: PTF 400 mg bid
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: PTF 400 mg tid
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: PTF 400 mg bid or tid
Number of subjects: 25
Study: 1417051

Group type: EXPERIMENTAL
Intervention: Antipseudomonal treatment at intervals of four months until serum IgG titre returned to control range
Number of subjects: 19

Group type: COMPARATOR
Intervention: Observation (no antipseudomonal treatment)
Number of subjects: 19
Study: 3880879

Group type: EXPERIMENTAL
Intervention: Dexamethasone therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no dexamethasone)
Number of subjects: 0
Study: 29534125

Group type: EXPERIMENTAL
Intervention: MicroSaw
Number of subjects: 53

Group type: COMPARATOR
Intervention: Piezosurgery
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: MicroSaw and Piezosurgery
Number of subjects: 53
Study: 26509236

Group type: EXPERIMENTAL
Intervention: Combined physical exercise and psychosocial intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 68
Study: 26158769

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise
Number of subjects: 222

Group type: COMPARATOR
Intervention: Control (usual exercise)
Number of subjects: 222
Study: 24016454

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 18113

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18113
Study: 20950304

Group type: EXPERIMENTAL
Intervention: Sildenafil for the treatment of mild ED
Number of subjects: 176

Group type: COMPARATOR
Intervention: General ED clinical trial population
Number of subjects: 176
Study: 18296978

Group type: EXPERIMENTAL
Intervention: Aerobic cardioacceleration before each set of resistance exercises
Number of subjects: 48

Group type: COMPARATOR
Intervention: Rest (control group)
Number of subjects: 48
Study: 16571739

Group type: EXPERIMENTAL
Intervention: Bilateral flickering stimuli presented continuously over entire trial blocks with subjects counting target letter 'X' in the cued hemifield.
Number of subjects: 0
Study: 15110129

Group type: EXPERIMENTAL
Intervention: Enfuvirtide
Number of subjects: 885

Group type: COMPARATOR
Intervention: Control
Number of subjects: 885
Study: 11096333

Group type: EXPERIMENTAL
Intervention: Acamprosate (6 tablets of 333 mg per day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9129859

Group type: EXPERIMENTAL
Intervention: Irwin's restricted mean
Number of subjects: 0

Group type: COMPARATOR
Intervention: Logrank test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Censored data generalization of the Wilcoxon test
Number of subjects: 0
Study: 8171300

Group type: EXPERIMENTAL
Intervention: Various interventions used in treatment trials
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3524696

Group type: EXPERIMENTAL
Intervention: Psychopharmacological treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 29733647

Group type: EXPERIMENTAL
Intervention: Flocculant-disinfectant sachets in Pakistan
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flocculant-disinfectant sachets in Zambia
Number of subjects: 0
Study: 27809814

Group type: EXPERIMENTAL
Intervention: Complementary communication training program (9 hours e-learning + 20 hours on-site skills training)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group without training
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Complementary communication training program
Number of subjects: 137
Study: 24833256

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Comparator antibiotics
Number of subjects: 1024
Study: 22508435

Group type: EXPERIMENTAL
Intervention: Wellness Recovery Action Planning (WRAP) intervention, consisting of eight weekly 2.5-hour sessions delivered by peers in recovery from serious mental illness.
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Wellness Recovery Action Planning (WRAP) intervention
Number of subjects: 519

Group type: COMPARATOR
Intervention: Services as usual (control group)
Number of subjects: 519
Study: 20516308

Group type: EXPERIMENTAL
Intervention: Smoking cessation program for six weeks
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (no smoking cessation program)
Number of subjects: 105
Study: 18609709

Group type: EXPERIMENTAL
Intervention: Triple therapy (LAC): lansoprazole 30 mg, amoxycillin 1 g, clarithromycin 500 mg, all b.d.
Number of subjects: 101

Group type: COMPARATOR
Intervention: Quadruple therapy (LMBT): lansoprazole 30 mg b.d., metronidazole 500 mg t.d.s., bismuth subcitrate 240 mg b.d., tetracycline chloride 500 mg q.d.s.
Number of subjects: 101
Study: 16077990

Group type: EXPERIMENTAL
Intervention: CDDP + 5-FU
Number of subjects: 197

Group type: COMPARATOR
Intervention: CDDP + VP16
Number of subjects: 197
Study: 11346861

Group type: EXPERIMENTAL
Intervention: 4 mg zoledronic acid
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: 8 mg zoledronic acid
Number of subjects: 287

Group type: COMPARATOR
Intervention: 90 mg pamidronate
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: 4 mg and 8 mg zoledronic acid
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: 8 mg zoledronic acid (retreatment)
Number of subjects: 287
Study: 9212042

Group type: EXPERIMENTAL
Intervention: L-T4 treatment (20 microg/kg daily for 2 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 40
Study: 7963146

Group type: EXPERIMENTAL
Intervention: Microparticulated protein (MPP, Simplesse) frozen dessert
Number of subjects: 24

Group type: COMPARATOR
Intervention: Super premium ice cream (approximately 16% butterfat)
Number of subjects: 24
Study: 3309757

Group type: EXPERIMENTAL
Intervention: Thymostimulin for 2 weeks after the second cycle of chemotherapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no additional immunotherapy)
Number of subjects: 20
Study: 28635021

Group type: EXPERIMENTAL
Intervention: Objectification (body focus)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Provocation (yes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No objectification
Number of subjects: 0
Study: 27686345

Group type: EXPERIMENTAL
Intervention: Lower threshold (transfusion at 7 g/dl or less)
Number of subjects: 1005

Group type: COMPARATOR
Intervention: Higher threshold (transfusion at 9 g/dl or less)
Number of subjects: 1005
Study: 23438305

Group type: EXPERIMENTAL
Intervention: Islet preparations with microbial contamination (19 out of 343, 5.5%)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Islet preparations with microbial contamination
Number of subjects: 164
Study: 21256472

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted colorectal resection
Number of subjects: 52

Group type: COMPARATOR
Intervention: Open colorectal resection
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Nerve sparing surgery (not performed)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Vaginal resection
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Parametrial resection
Number of subjects: 52
Study: 19920414

Group type: EXPERIMENTAL
Intervention: Dextrose 5% in water (D5W)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 50
Study: 16566619

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 142
Study: 14631328

Group type: EXPERIMENTAL
Intervention: Individualized training for 2 months
Number of subjects: 28
Study: 10945310

Group type: EXPERIMENTAL
Intervention: Oral coadministration of 100 mg talinolol with 0.5 mg digoxin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Coinfusion of 30 mg talinolol with oral digoxin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Digoxin alone
Number of subjects: 10
Study: 9433787

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 8280829

Group type: EXPERIMENTAL
Intervention: Reducing dietary fat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trial participation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Suggestions for adherence
Number of subjects: 0